Evidence map›Paper›PMID 30120336›Full record

ArticleScientific reports2018

Genome-wide Association Analysis of Eye Movement Dysfunction in Schizophrenia.

Masataka Kikuchi, Kenichiro Miura, Kentaro Morita, Hidenaga Yamamori, Michiko Fujimoto, Masashi Ikeda, Yuka Yasuda, Akihiro Nakaya, Ryota Hashimoto

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Masataka KikuchiDepartment of Genome Informatics, Graduate School of Medicine, Osaka University, Osaka, Japan.
Kenichiro MiuraDepartment of Integrative Brain Science, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kentaro MoritaDepartment of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Hidenaga YamamoriDepartment of Psychiatry, Graduate School of Medicine, Osaka University, Osaka, Japan.
Michiko FujimotoDepartment of Psychiatry, Graduate School of Medicine, Osaka University, Osaka, Japan.
Masashi IkedaDepartment of Psychiatry, Fujita Health University School of Medicine, Aichi, Japan.
Yuka YasudaDepartment of Psychiatry, Graduate School of Medicine, Osaka University, Osaka, Japan.
Akihiro NakayaDepartment of Genome Informatics, Graduate School of Medicine, Osaka University, Osaka, Japan.
Ryota HashimotoDepartment of Psychiatry, Graduate School of Medicine, Osaka University, Osaka, Japan. hashimor@psy.med.osaka-u.ac.jp.ORCID 0000-0002-5941-4238

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eye movements are considered endophenotypes of schizophrenia. However, the genetic factors underlying eye movement are largely unknown. In this study, we explored the susceptibility loci for four eye movement scores: the scanpath length during the free viewing test (SPL), the horizontal position gain during the fast Lissajous paradigm of the smooth pursuit test (HPG), the duration of fixations during the far distractor paradigm of the fixation stability test (DF) and the integrated eye movement score of those three scores (EMS). We found 16 SNPs relevant to the HPG that were located in 3 genomic regions (1q21.3, 7p12.1 and 20q13.12) in the patient group; however, these SNPs were intronic or intergenic SNPs. To determine whether these SNPs occur in functional non-coding regions (i.e., enhancer or promoter regions), we examined the chromatin status on the basis of publicly available epigenomic data from 127 tissues or cell lines. This analysis suggested that the SNPs on 1q21.3 and 20q13.12 are in enhancer or promoter regions. Moreover, we performed an analysis of expression quantitative trait loci (eQTL) in human brain tissues using a public database. Finally, we identified significant eQTL effects for all of the SNPs at 1q21.3 and 20q13.12 in particular brain regions.

Indexed as

Eye MovementsGenetic Predisposition to DiseaseGenome-Wide Association StudyAdultCase-Control StudiesChromosome MappingEye Movement MeasurementsFemaleGenomicsHumansMaleMiddle AgedOcular Motility DisordersQuantitative Trait, HeritableQuantitative Trait LociRNA, UntranslatedRNA, Untranslated

Identifiers

PMID30120336
PMCPMC6098030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.